5D Capital Corp Portfolio

Origin Therapeutics is helping to bring psychedelic therapeutic treatments to market. This Global Psychedelic fund is investing in a diverse range of psychedelic companies to provide exposure and help push the industry forward. Their powerhouse team of experts identify emerging global innovators who are supported by science because they believe this industry has the potential to revolutionize mental health care. Origin Therapeutics is investing in the betterment of us all.